Nesiritide Price Comparison

View full research →
Acute decompensated congestive heart failureSafety Rating 8/10

Price Comparison

Compare vendors

No vendor pricing available for this peptide yet.

Research details

Nesiritide — research data

Research-literature reference data, NOT patient instructions. Not for human use. Consult a licensed clinician for any human application.

Research dose range2 mcg/kg IV bolus then 0.01 mcg/kg/min infusion
AdministrationIntravenous
Safety8/10 · FDA-approved (Natrecor)
NCAA D1Not listed

Overview

About Nesiritide

Mechanism of action

Recombinant human BNP; vasodilation and natriuresis via cGMP signaling

Safety profile

Hypotension, renal function concerns; limited current use · Approved for acute HF; hypotension risk; renal concerns debated; fell out of favor clinically

📈

Price tracking starts now.

Set an alert to get notified when this peptide drops.

Related pages

More on Nesiritide

Failed to fetch